11 October 2023
11 October 2023
The Israel Ministry of Health has contingencies in place to continue clinical trial operations in the country during times of conflict.
The data shows that the NovaGuide Intelligent Ultrasound system is superior in detecting right to left shunt than the current standard of care.
The IDE is for a second multicentre study to test the sensor in New York Heart Association (NYHA) class II heart failure patients.
The treatment caused rapid clearance of symptoms in patients with psoriasis, but Anaptys intends to out-licence the drug.
The company completed the dose escalation portion of a Phase I trial of GFH009 for hematological malignancies.
Nearly 600 patients have received treatment using BOT in the Phase I and Phase II clinical studies.
In the study, AVB-101 will be delivered into the patient's thalamus through a stereotactic neurosurgical procedure.
Each subject will receive six paraspinal intramuscular injections of CELZ-201-DDT, or a placebo, into the lumbar musculature.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
